ALLTEST Prostate Specific Antigen (PSA) Test Kits

Wholesale Prostate Cancer Testing Kits.

The AllTest PSA Rapid Test Cassette (Whole Blood/Serum/Plasma) (REF: TPS-402) is a rapid chromatographic immunoassay designed for the semi-quantitative detection of Prostate Specific Antigen (PSA) in human whole blood, serum or plasma specimens. The professional version incorporates a unique reference (R) line, allowing healthcare professionals to estimate PSA concentrations by comparing the intensity of the test line with the reference line. Results indicate PSA levels below 3 ng/mL, between 3–10 ng/mL, or above 10 ng/mL, providing valuable information to support further clinical assessment. Results are available in approximately 5 minutes, and the test is intended for professional in vitro diagnostic use. It is CE marked for quality and regulatory compliance.

Alongside the professional test, AllTest also manufactures a home-use PSA Rapid Test, which is designed for consumer self-testing. Rather than using a reference line to estimate PSA concentration, the home version uses a single test (T) line with a 4 ng/mL cut-off, providing a simple positive or negative result that is easy to interpret outside of a clinical setting. Both versions are designed to support the early detection of elevated PSA levels, which may be associated with prostate cancer, benign prostatic hyperplasia (BPH) or prostatitis. While PSA testing is a valuable screening aid, results should always be interpreted alongside clinical findings and, where appropriate, followed by further diagnostic investigation.

Prostate Specific Antigen (PSA) is a protein produced by cells of the prostate gland and is one of the most widely used biomarkers in prostate health screening. Elevated PSA levels may be associated with prostate cancer, but can also occur in benign conditions such as benign prostatic hyperplasia (BPH) and prostatitis. Rapid PSA testing can help healthcare professionals identify patients who may benefit from further clinical assessment, including additional laboratory testing or prostate biopsy where appropriate. Used alongside patient history, physical examination and other diagnostic investigations, this rapid test provides a convenient method for supporting early clinical decision-making and prostate disease management.